The growth of DAOs is a significant trend within DeSci, with over 20 DAOs operating in medicine’s next innovation wave.
VitaDAO, a decentralized collective focusing on longevity research, exemplifies the potential of DeSci.
VitaDAO’s awareness steward, Alex Dobrin, emphasizes the model’s scalability and effectiveness in funding and supporting projects. The decentralized nature allows anyone to contribute skills and capital, fostering a collaborative and aligned approach.
DeSci proponents argue that decentralizing science can address the misaligned incentives in the current centralized medical profession. This is especially a factor in pharmaceuticals.
Tyler Golato, co-founder of Molecule, a decentralized biotech firm, highlights the positive impact on medical and pharmaceutical industries when incentives are realigned.
Advancing Medicine
One of DeSci’s strengths lies in its ability to involve individuals from diverse disciplines and backgrounds.
Individual contributors, like Sara Peoples of AthenaDAO, bring unique skill sets to the community, contributing to advancements in various fields, including women’s health.
